Koyfin Home > Directory > Health Care > Kindred Biosciences > Return on Capital %

Kindred Biosciences Return on Capital % Chart (KIN)

Kindred Biosciences annual/quarterly Return on Capital % from 2013 to 2020.
  • Kindred Biosciences Return on Capital % for the quarter ending June 06, 2020 was -31.12 a -11.61% increase of 3.61 year over year
  • Kindred Biosciences Return on Capital % for the last 12 months ending June 06, 2020 was -36.35 a 1.79% decrease of -0.65 year over year
  • Kindred Biosciences Annual Return on Capital % for 2019 was -39.97 a 8.87% decrease of -3.55 from 2018
  • Kindred Biosciences Annual Return on Capital % for 2018 was -36.43 a 23.70% decrease of -8.63 from 2017
  • Kindred Biosciences Annual Return on Capital % for 2017 was -27.79 a 25.62% decrease of -7.12 from 2016
Other Margins & Efficiency Metrics:
  • Kindred Biosciences Return on Equity % for the quarter ending September 09, 2018 was -47.37 a 7.47% decrease of -3.54 year over year
View Chart On Koyfin

Quarterly KIN Return on Capital % Data

06/2020-31.12
03/2020-55.21
12/2019-35.16
09/2019-34.73
06/2019-31.71
03/2019-38.98
12/2018-40.54
09/2018-30.78
06/2018-30.19
03/2018-31.86

Annual KIN Return on Capital % Data

2019-39.97
2018-36.43
2017-27.79
2016-20.67
2015-19.43
2014-20.97
2013-8.22